| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
30,552 |
27,455 |
$2.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,095 |
17,773 |
$1.10M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
8,362 |
7,476 |
$777K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,424 |
7,871 |
$548K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,298 |
14,020 |
$426K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15,335 |
14,279 |
$384K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,077 |
1,555 |
$208K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,047 |
5,513 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,257 |
1,169 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,529 |
1,462 |
$43K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
527 |
486 |
$35K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,061 |
1,533 |
$34K |
| 87581 |
|
2,060 |
1,534 |
$34K |
| 87486 |
|
2,057 |
1,533 |
$27K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
920 |
808 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,733 |
3,226 |
$25K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
500 |
485 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
349 |
348 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
286 |
271 |
$5K |
| 81002 |
|
1,764 |
1,603 |
$5K |
| 87807 |
|
406 |
368 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,011 |
1,758 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
81 |
51 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
408 |
349 |
$570.04 |